MedPath

Irinotecan hydrochloide

These highlights do not include all the information needed to use IRINOTECAN HYDROCHLORIDE INJECTION safely and effectively. See full prescribing information for IRINOTECAN HYDROCHLORIDE INJECTION. IRINOTECAN HYDROCHLORIDE injection, for intravenous use Initial U.S. Approval: 1996

Approved
Approval ID

de634e80-328a-4473-b395-0172683a2411

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Mar 3, 2022

Manufacturers
FDA

Gland Pharma Limited

DUNS: 918601238

Products 2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Irinotecan hydrochloride

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code68083-382
Application NumberANDA212993
Product Classification
M
Marketing Category
C73584
G
Generic Name
Irinotecan hydrochloride
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateMarch 3, 2022
FDA Product Classification

INGREDIENTS (5)

HYDROCHLORIC ACIDInactive
Code: QTT17582CB
Classification: IACT
IRINOTECAN HYDROCHLORIDEActive
Quantity: 20 mg in 1 mL
Code: 042LAQ1IIS
Classification: ACTIB
LACTIC ACIDInactive
Code: 33X04XA5AT
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
SORBITOLInactive
Code: 506T60A25R
Classification: IACT

Irinotecan hydrochloide

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code68083-381
Application NumberANDA212993
Product Classification
M
Marketing Category
C73584
G
Generic Name
Irinotecan hydrochloide
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateMarch 3, 2022
FDA Product Classification

INGREDIENTS (5)

IRINOTECAN HYDROCHLORIDEActive
Quantity: 20 mg in 1 mL
Code: 042LAQ1IIS
Classification: ACTIB
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
LACTIC ACIDInactive
Code: 33X04XA5AT
Classification: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CB
Classification: IACT
SORBITOLInactive
Code: 506T60A25R
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Irinotecan hydrochloide - FDA Drug Approval Details